共 50 条
- [1] Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trialLANCET NEUROLOGY, 2015, 14 (01) : 39 - 47Angus, D.Herd, C.Stone, C.Stout, J.Wieler, M.Reilmann, R.Ritchie, C. W.Dorsey, E. R.Helles, K.Kayson, E.Oakes, D.Rosas, H. D.Vaughan, C.Panegyres, P. K.Ames, D.Goh, A.Agarwal, P.Churchyard, A.Murathodizic, M.Chua, P.Germaine, D.Lim, L.Mack, H.Loy, C.Griffith, J.Mitchell, P.Corey-Bloom, J.Gluhm, S.Goldstein, J.Levi, L.Margolis, R.Yoritomo, N.Janicki, S.Marder, K.Clouse, R.Singer, C.Moore, H.Padron, N.Kostyk, S.Daley, A.Segro, V.Kumar, R.Anderson, K.Drazinic, C.Hennig, B.Nance, M.Molho, E.Criswell, S.LeDoux, M. S.Guyot, S.
- [2] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIALNEUROLOGY, 2015, 85 (23) : 2083 - 2084Tufan, Ayse N.Tufan, Fatih
- [3] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialNEUROLOGY, 2015, 84 (21) : 2161 - 2168Butchart, JosephBrook, LauraHopkins, VivienneTeeling, JessicaPuentener, UrsulaCulliford, DavidSharples, RichardSharif, SaifMcFarlane, BradyRaybould, RachelThomas, RhodriPassmore, PeterPerry, V. HughHolmes, Clive
- [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's DiseaseMOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415Kieburtz, KarlMcGarry, AndrewMcDermott, MichaelKayson, EliseHarrison, MadalineMarder, KarenWalker, Francis
- [5] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL ResponseNEUROLOGY, 2015, 85 (23) : 2084 - 2084Holmes, Clive
- [6] A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Cysteamine in Huntington's DiseaseMOVEMENT DISORDERS, 2017, 32 (06) : 932 - 936Verny, ChristopheBachoud-Levi, Anne-CatherineDurr, AlexandraGoizet, CyrilAzulay, Jean-PhilippeSimonin, ClemenceTranchant, ChristineCalvas, FabienneKrystkowiak, PierreCharles, PerrineYoussov, KatiaScherer, ClarissePrundean, AdrianaOlivier, AudreyReynier, PascalSaudou, FredericMaison, PatrickAllain, Philippevon Studnitz, EricaBonneau, Dominique
- [7] Ethyl-EPA in Huntington disease - A double-blind, randomized, placebo-controlled trialNEUROLOGY, 2005, 65 (02) : 286 - 292Puri, BKLeavitt, BRHayden, MRRoss, CARosenblatt, AGreenamyre, JTHersch, SVaddadi, KSSword, AHorrobin, DFManku, MMurck, H
- [8] Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trialLANCET NEUROLOGY, 2008, 7 (09) : 779 - 786Lannfelt, LarsBlennow, KajZetterberg, HenrikBatsman, StellanAmes, DavidHrrison, JohnMasters, Colin L.Targum, SteveBush, Ashley I.Murdoch, RossWilson, JanetRitchie, Craig W.
- [10] Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomized, double-blind, placebo-controlled trialPRION, 2013, 7 : 62 - 62Brandel, Jean-PhilippeMarcon, GabriellaCoudert, MathieuTettamanti, MauroWelaratne, ArletteGiacone, GeorgioAzimi, ShohrehPietrini, VladimiroFabreguettes, Jean-RochImperiale, DanieleAucan, ChristopheLucca, UgoMallet, AlainSalmona, MarioZerr, IngaRedaelli, VeronicaForloni, GianluigiHaik, StephaneTagliavini, Fabrizio
